CDEK
← All organizations

Intersect ENT

For profitWebsite ↗

Also known as: Intersect ENT | INTERSECT ENT INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2013

First marketed drug

Dec 8, 2017

Last known activity

Dec 8, 2017

Acquired by Medtronic on Aug 9, 2021

Timeline

2000s

  1. Jan 1, 2003

    Intersect ENT— Founded

2010s

  1. Dec 8, 2017

    mometasone— NDA Secondary Org

2020s

  1. Aug 9, 2021

    Medtronic— Acquired By

Drugs by trial phase (1 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (3)

Details

Founded
Menlo Park, CA, US Jan 1, 2003
Last known activity
Dec 8, 2017